Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease

Clinical trial NCT00280956 · COMPLETED

Trial details

NCT number: NCT00280956
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2002-07-01
Primary completion: 2004-09-01
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.